196 related articles for article (PubMed ID: 32814635)
41. Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.
Gemmati D; Tisato V
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899439
[TBL] [Abstract][Full Text] [Related]
42. Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients.
Hoechter DJ; Becker-Pennrich A; Langrehr J; Bruegel M; Zwissler B; Schaefer S; Spannagl M; Hinske LC; Zoller M
Thromb Res; 2020 Dec; 196():186-192. PubMed ID: 32891904
[TBL] [Abstract][Full Text] [Related]
43. The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis.
Liu N; Zhang T; Ma L; Zhang H; Wang H; Wei W; Pei H; Li H
Blood Rev; 2021 Jul; 48():100785. PubMed ID: 33309392
[TBL] [Abstract][Full Text] [Related]
44. ABO blood groups and risk of covid-19.
Yalaoui S; Fakhfakh R; Tritar F; Chaouch N; Mestiri T; Besbes M; Hamzaoui A
Tunis Med; 2020 Dec; 98(12):888-891. PubMed ID: 33479990
[TBL] [Abstract][Full Text] [Related]
45. Retrospective analysis of clinical features in 134 coronavirus disease 2019 cases.
Zhang L; Huang B; Xia H; Fan H; Zhu M; Zhu L; Zhang H; Tao X; Cheng S; Chen J
Epidemiol Infect; 2020 Sep; 148():e199. PubMed ID: 32878654
[TBL] [Abstract][Full Text] [Related]
46. Lack of association between ABO blood groups and susceptibility to SARS-CoV-2 infection.
Levi JE; Telles PR; Scrivani H; Campana G
Vox Sang; 2021 Feb; 116(2):251-252. PubMed ID: 33103769
[No Abstract] [Full Text] [Related]
47. ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data.
Pendu JL; Breiman A; Rocher J; Dion M; Ruvoën-Clouet N
Viruses; 2021 Jan; 13(2):. PubMed ID: 33499228
[TBL] [Abstract][Full Text] [Related]
48. Association of ABO/Rh with SARS-CoV-2 positivity: The role of race and ethnicity in a female cohort.
Niles JK; Karnes HE; Dlott JS; Kaufman HW
Am J Hematol; 2021 Jan; 96(1):E23-E26. PubMed ID: 33064308
[No Abstract] [Full Text] [Related]
49. Questioning the association between ABO type and outcomes in patients with COVID-19.
May JE; McGwin G; Gangaraju R; Paschal R; Weaver K; Lima JLO; Marques MB
Ann Hematol; 2021 Dec; 100(12):3081-3082. PubMed ID: 33205336
[No Abstract] [Full Text] [Related]
50. Risk and Severity of COVID-19 and ABO Blood Group in Transcatheter Aortic Valve Patients.
Kibler M; Dietrich L; Kanso M; Carmona A; Marchandot B; Matsushita K; Trimaille A; How-Choong C; Odier A; Gennesseaux G; Schramm O; Reydel A; Hess S; Sato C; Caillard S; Jesel L; Morel O; Ohlmann P
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33266474
[TBL] [Abstract][Full Text] [Related]
51. ABO blood groups in COVID-19 patients; Cross-sectional study.
Solmaz İ; Araç S
Int J Clin Pract; 2021 Apr; 75(4):e13927. PubMed ID: 33296536
[TBL] [Abstract][Full Text] [Related]
52. Association between the dynamics of the COVID-19 epidemic and ABO blood type distribution.
Liu Y; Häussinger L; Steinacker JM; Dinse-Lambracht A
Epidemiol Infect; 2021 Jan; 149():e19. PubMed ID: 33407977
[TBL] [Abstract][Full Text] [Related]
53. HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity.
Amoroso A; Magistroni P; Vespasiano F; Bella A; Bellino S; Puoti F; Alizzi S; Vaisitti T; Boros S; Grossi PA; Trapani S; Lombardini L; Pezzotti P; Deaglio S; Brusaferro S; Cardillo M;
Transplantation; 2021 Jan; 105(1):193-200. PubMed ID: 33141807
[TBL] [Abstract][Full Text] [Related]
54. Covid-19 and blood groups: ABO antibody levels may also matter.
Deleers M; Breiman A; Daubie V; Maggetto C; Barreau I; Besse T; Clémenceau B; Ruvoën-Clouet N; Fils JF; Maillart E; Doyen V; Mahadeb B; Jani JC; Van der Linden P; Cannie MM; Hayef N; Corazza F; Le Pendu J; El Kenz H
Int J Infect Dis; 2021 Mar; 104():242-249. PubMed ID: 33326874
[TBL] [Abstract][Full Text] [Related]
55. Clinical, regional, and genetic characteristics of Covid-19 patients from UK Biobank.
Kolin DA; Kulm S; Christos PJ; Elemento O
PLoS One; 2020; 15(11):e0241264. PubMed ID: 33201886
[TBL] [Abstract][Full Text] [Related]
56. COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies.
Di Minno A; Ambrosino P; Calcaterra I; Di Minno MND
Semin Thromb Hemost; 2020 Oct; 46(7):763-771. PubMed ID: 32882719
[TBL] [Abstract][Full Text] [Related]
57. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.
Houston BL; Lawler PR; Goligher EC; Farkouh ME; Bradbury C; Carrier M; Dzavik V; Fergusson DA; Fowler RA; Galanaud JP; Gross PL; McDonald EG; Husain M; Kahn SR; Kumar A; Marshall J; Murthy S; Slutsky AS; Turgeon AF; Berry SM; Rosenson RS; Escobedo J; Nicolau JC; Bond L; Kirwan BA; de Brouwer S; Zarychanski R
Clin Trials; 2020 Oct; 17(5):491-500. PubMed ID: 32815416
[TBL] [Abstract][Full Text] [Related]
58. Lack of association between SNPsrs8176719 (O blood group) and COVID-19: Data from Spanish age matched patients and controls.
Coto E; Albaiceta GM; Clemente MG; Gómez J
Transfusion; 2021 Feb; 61(2):654-656. PubMed ID: 33191530
[No Abstract] [Full Text] [Related]
59. Venous Thromboembolism in Hospitalized COVID-19 Patients.
Sridharan GK; Vegunta R; Rokkam VRP; Meyyur Aravamudan V; Vegunta R; Khan SR; Ponnada S; Boregowda U; Prudhvi K; Chamarthi G; Mohan BP
Am J Ther; 2020; 27(6):e599-e610. PubMed ID: 33156016
[TBL] [Abstract][Full Text] [Related]
60. Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19.
Piazza G; Campia U; Hurwitz S; Snyder JE; Rizzo SM; Pfeferman MB; Morrison RB; Leiva O; Fanikos J; Nauffal V; Almarzooq Z; Goldhaber SZ
J Am Coll Cardiol; 2020 Nov; 76(18):2060-2072. PubMed ID: 33121712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
